RobertsDissertation
1 SlideShare 1 Seguidor 25 Siguiendos
Etiquetas
viral diseases tamiflu viread influenza hepatitis b hiv biotechnology michael riordan gilead michael l riordan gilead sciences
Ver más

Documentos

(1)

From Startup to Blue Chip: The Success Story of Gilead Sciences Inc.

Hace 3 años • 18 Visualizaciones

Recomendaciones

(10)
Ver todo

Promise Seen in Antisense Medicine and Neutralizing Harmful Genes

GatewayAvenue • Hace 3 años

Riordan (Gilead Sciences) Schmergel (Genetics Institute) Vincent (Biogen) Biotech Roundtable 1991 by G Steven Burrill

ArrowDyn • Hace 7 años

Medicine: An Apt Preparation for Public Office, by Michael Lee Riordan; Postgraduate Medicine, 1984

Sterlingcourt • Hace 3 años

Groundbreaking Czech Chemist Antonin Holy Dies at Age 75: Radio Prague International

BoylstonReview • Hace 3 años

Antisense Oligonucleotides, Aptamers & Triple Helix: Speech by Michael L Riordan, the Founder of Gilead Sciences

EduConnections • Hace 3 años

The Path to Public Office: Medicine versus Law, by Michael L. Riordan

Perspectivestoday • Hace 10 años

Michael L Riordan, the founder of Gilead Sciences, at whiteboard in office (1990)

AlumniLink • Hace 6 años

Michael L Riordan Started Gilead Sciences in 1987: Nasdaq article "Gilead Sciences: A Biotech Powerhouse"

WallStreetHistory • Hace 3 años

"State of the Gilead" presentation by Dr. Michael L. Riordan, the founder and CEO of Gilead Sciences, in July 1992

presentationselect • Hace 10 años

Gilead Sciences: First 15 Years | Article by Funding Universe

BPowell4 • Hace 3 años
Etiquetas
viral diseases tamiflu viread influenza hepatitis b hiv biotechnology michael riordan gilead michael l riordan gilead sciences
Ver más